Evaluation of infections in renal transplant recipients treated with cyclosporine.
Carmellini
M
M
Istituto di Chirurgia Generale e Sperimentale, Università degli Studi di Pisa, Italia.
Romagnoli
J
J
Pietrabissa
A
A
Di Stefano
R
R
Oleggini
M
M
Rindi
P
P
Rizzo
G
G
Mosca
F
F
D000961:Antilymphocyte Serum / Q000009:adverse effects / Q000627:therapeutic use; D003141:Communicable Diseases / Q000453:epidemiology* / Q000276:immunology; D016572:Cyclosporine / Q000009:adverse effects / Q000627:therapeutic use*; D005500:Follow-Up Studies; D006801:Humans; D007165:Immunosuppression Therapy / Q000009:adverse effects; D015994:Incidence; D016030:Kidney Transplantation / Q000276:immunology*; D008171:Lung Diseases / Q000453:epidemiology / Q000276:immunology; D016853:Muromonab-CD3 / Q000009:adverse effects / Q000627:therapeutic use; D012189:Retrospective Studies; D013997:Time Factors
D000961:Antilymphocyte Serum; D016853:Muromonab-CD3; D016572:Cyclosporine